We recently published a list of the 13 Best American Dividend Stocks to Buy According to Analysts. In this article, we are ...

The board of Johnson & Johnson ( NYSE:JNJ ) has announced that the dividend on 10th of June will be increased to ...

The company posted adjusted earnings of $2.77 per share on revenue of $21.9 billion, exceeding consensus estimates of $2.59 ...

We recently published a list of Jim Cramer Says Trump’s Fed Chair Tussle Is Like “The Godfather” & Discusses These 10 Stocks.

Key Points Johnson & Johnson is pulling back as tariffs weigh on investors.  Not helping, JNJ just forecasted $400 million in ...

The Dow Jones Industrial Average (DJIA) index rallied on Wednesday as investors continued to regain confidence in the economy ...

Protagonist Therapeutics, Inc. (”Protagonist” or the “Company”) announced that an abstract was accepted for presentation at the Plenary Session at the American Society of Clinical Oncology (ASCO) ...

Multinational healthcare company Johnson & Johnson (NYSE:JNJ) in Q1 CY2025, with sales up 2.4% year on year to $21.89 billion ...

Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors.

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy for oncologists treating patients in a community setting.

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best low volatility stocks to buy now. The US stock market experienced a turbulent first ...